NASDAQ: AARD 0.94%

---

AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit

NASDAQ: CRDL 0.94%

---

Buy Recommendation Issued On CRDL By B. Riley